Gossamer Bio, Inc. - COM (GOSS)

Historical Portfolio Holders from Q1 2019 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
183M
Holdings value Q2 2024
$165M
Value change Q2 2024
-$20M
Grand Portfolio weight change Q2 2024
0%
Number of holders
93
Number of buys Q2 2024
8
Number of sells Q2 2024
-4
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.33M $1.29M +$367K $0.99 14
2024 Q2 183M $165M -$20M $0.90 93
2024 Q1 198M $234M -$11.2M $1.18 105
2023 Q4 203M $185M +$4.88M $0.91 96
2023 Q3 206M $171M +$118M $0.83 93
2023 Q2 62M $74.4M -$19.2M $1.20 93
2023 Q1 77.7M $97.9M -$40.1M $1.26 107
2022 Q4 104M $225M -$165M $2.17 116
2022 Q3 85.2M $1.02B +$262M $11.98 156
2022 Q2 63.7M $533M +$32.5M $8.37 128
2022 Q1 59.9M $520M +$5.18M $8.68 138
2021 Q4 58.8M $665M +$43.2M $11.31 129
2021 Q3 54.7M $688M +$24M $12.57 123
2021 Q2 53.1M $431M -$10.2M $8.12 108
2021 Q1 54.3M $502M +$8.87M $9.25 120
2020 Q4 53.1M $514M -$47.1M $9.67 120
2020 Q3 55.5M $689M +$37.3M $12.41 123
2020 Q2 52.5M $684M +$177M $13.00 110
2020 Q1 39M $396M -$15.7M $10.15 95
2019 Q4 40.4M $632M -$16.7M $15.63 90
2019 Q3 41.3M $694M +$154M $16.79 80
2019 Q2 36.7M $813M +$18.8M $22.18 74
2019 Q1 35.9M $776M +$776M $21.67 71